$EMMA
Emmaus Life Sciences, Inc.

2022 Q3 Form 10-Q Financial Statement

#000156459022029481 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $4.939M $4.287M $3.234M
YoY Change -14.34% -33.93% -39.38%
Cost Of Revenue $540.0K $396.0K $1.007M
YoY Change 21.35% -7.91% 130.96%
Gross Profit $4.399M $3.891M $2.227M
YoY Change -17.33% -35.78% -54.54%
Gross Profit Margin 89.07% 90.76% 68.86%
Selling, General & Admin $4.627M $5.033M $4.829M
YoY Change -5.22% 4.35% 2.64%
% of Gross Profit 105.18% 129.35% 216.84%
Research & Development $432.0K $298.0K $466.0K
YoY Change -8.09% -60.42% -74.24%
% of Gross Profit 9.82% 7.66% 20.93%
Depreciation & Amortization $9.000K $10.00K $11.00K
YoY Change -18.18% -16.67% -26.67%
% of Gross Profit 0.2% 0.26% 0.49%
Operating Expenses $5.059M $5.331M $5.295M
YoY Change -5.47% -4.39% -18.71%
Operating Profit -$660.0K -$1.440M -$3.068M
YoY Change 2029.03% -398.14% 89.97%
Interest Expense $1.520M $1.287M $737.0K
YoY Change -149.35% 97.09% -30.08%
% of Operating Profit
Other Income/Expense, Net $175.0K $133.0K $222.0K
YoY Change -8.85% -30.37% 16.84%
Pretax Income -$426.0K -$8.710M -$1.645M
YoY Change -85.41% -479.19% -80.43%
Income Tax -$35.00K $182.0K -$103.0K
% Of Pretax Income
Net Earnings -$391.0K -$8.892M -$1.542M
YoY Change -87.59% -457.25% -81.69%
Net Earnings / Revenue -7.92% -207.42% -47.68%
Basic Earnings Per Share -$0.01 -$0.18 -$0.03
Diluted Earnings Per Share -$0.01 -$0.18 -$31.27K
COMMON SHARES
Basic Shares Outstanding 49.56M 49.32M 49.31M
Diluted Shares Outstanding 49.56M 49.32M 49.31M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.179M $982.0K $813.0K
YoY Change -49.2% -41.23% -78.37%
Cash & Equivalents $1.179M $982.0K $813.0K
Short-Term Investments
Other Short-Term Assets $511.0K $422.0K $379.0K
YoY Change 104.4% 55.72% 59.92%
Inventory $2.739M $3.134M $3.453M
Prepaid Expenses $328.0K $435.0K $399.0K
Receivables $1.491M $1.235M $938.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.382M $6.586M $6.448M
YoY Change -48.84% -49.49% -54.4%
LONG-TERM ASSETS
Property, Plant & Equipment $79.00K $85.00K $138.0K
YoY Change -18.56% -14.14% 26.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.59M $16.98M $41.29M
YoY Change -61.9% -63.13% -5.58%
Other Assets $259.0K $261.0K $297.0K
YoY Change -11.6% -10.0% 1.37%
Total Long-Term Assets $35.82M $39.40M $45.05M
YoY Change -24.72% -21.57% -6.32%
TOTAL ASSETS
Total Short-Term Assets $6.382M $6.586M $6.448M
Total Long-Term Assets $35.82M $39.40M $45.05M
Total Assets $42.20M $45.99M $51.49M
YoY Change -29.73% -27.32% -17.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.407M $3.007M $2.873M
YoY Change 86.99% 126.43% 105.36%
Accrued Expenses $5.729M $6.196M $6.085M
YoY Change 23.1% 36.93% 50.36%
Deferred Revenue
YoY Change
Short-Term Debt $7.452M $11.39M $7.663M
YoY Change -3.63% 87.51% -12.92%
Long-Term Debt Due $19.98M $20.46M $12.86M
YoY Change 511.23% 521.57% 178.49%
Total Short-Term Liabilities $41.52M $46.08M $34.55M
YoY Change 65.92% 124.62% 41.56%
LONG-TERM LIABILITIES
Long-Term Debt $3.381M $0.00 $4.650M
YoY Change -76.53% -100.0% -61.87%
Other Long-Term Liabilities $32.12M $31.69M $31.51M
YoY Change -0.47% -8.07% -8.6%
Total Long-Term Liabilities $32.12M $31.69M $31.51M
YoY Change -0.47% -8.07% -8.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.52M $46.08M $34.55M
Total Long-Term Liabilities $32.12M $31.69M $31.51M
Total Liabilities $79.79M $80.62M $73.79M
YoY Change 6.16% 10.97% 25.33%
SHAREHOLDERS EQUITY
Retained Earnings -$252.5M -$252.1M
YoY Change
Common Stock $220.9M $220.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$37.59M -$34.64M -$22.30M
YoY Change
Total Liabilities & Shareholders Equity $42.20M $45.99M $51.49M
YoY Change -29.73% -27.32% -17.24%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$391.0K -$8.892M -$1.542M
YoY Change -87.59% -457.25% -81.69%
Depreciation, Depletion And Amortization $9.000K $10.00K $11.00K
YoY Change -18.18% -16.67% -26.67%
Cash From Operating Activities -$954.0K -$1.063M -$4.733M
YoY Change -158.17% -539.26% 18.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$16.00K $2.000K
YoY Change -100.0% 1500.0%
Acquisitions
YoY Change
Other Investing Activities -$900.0K -$1.636M $1.229M
YoY Change -29.47% -25.5% -169.47%
Cash From Investing Activities -$900.0K -$1.652M $1.227M
YoY Change -30.02% -24.81% -169.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.114M 2.893M 2.056M
YoY Change 604.67% -2242.96% -70.82%
NET CHANGE
Cash From Operating Activities -954.0K -1.063M -4.733M
Cash From Investing Activities -900.0K -1.652M 1.227M
Cash From Financing Activities 2.114M 2.893M 2.056M
Net Change In Cash 260.0K 178.0K -1.466M
YoY Change -60.24% -108.52% -215.25%
FREE CASH FLOW
Cash From Operating Activities -$954.0K -$1.063M -$4.733M
Capital Expenditures $0.00 -$16.00K $2.000K
Free Cash Flow -$954.0K -$1.047M -$4.735M
YoY Change -157.82% -530.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
14062000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49558501
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
50000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220800000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220022000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3339000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252146000
CY2022Q2 us-gaap Gross Profit
GrossProfit
3891000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
298000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1952000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3081000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
5331000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5576000
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
191000
us-gaap Interest And Other Income
InterestAndOtherIncome
355000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1287000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8892000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2489000
us-gaap Net Income Loss
NetIncomeLoss
-10434000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4415000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
546000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4065000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
604000
emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
157000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5172000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1440000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
483000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
CY2022Q2 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
542000
CY2021Q2 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
338000
CY2022Q2 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-3695000
CY2021Q2 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
2563000
emma Gain Loss On Investment In Convertible Bond
GainLossOnInvestmentInConvertibleBond
-133000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-493000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-582000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1059000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2470000
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-43000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3661000
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
133000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49319995
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49319995
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49311864
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49315952
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49193474
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
350000
CY2022Q1 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
331000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22299000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
213000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4415000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
643000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8892000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34635000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5158000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
500000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
181000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
58000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8422000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12676000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
274000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
546000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2489000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-9375000
us-gaap Profit Loss
ProfitLoss
-10434000
us-gaap Profit Loss
ProfitLoss
-5933000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30000
emma Inventory Reserve
InventoryReserve
-1008000
emma Inventory Reserve
InventoryReserve
-300000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
770000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1028000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3811000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1215000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
201000
emma Equity Securities Fv Ni Realized Gain Loss Excluding Impairment Loss
EquitySecuritiesFvNiRealizedGainLossExcludingImpairmentLoss
-133000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1059000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1336000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
emma Gain Loss On Sale Of Loss On Leased Assets
GainLossOnSaleOfLossOnLeasedAssets
-22000
us-gaap Share Based Compensation
ShareBasedCompensation
10000
us-gaap Share Based Compensation
ShareBasedCompensation
455000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
500000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1290000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-191000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-615000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
225000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
188000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3163000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-233000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-237000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-302000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-321000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-272000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
63000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-14000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1172000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-884000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3002000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
197000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-431000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-276000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5796000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3759000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2919000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-3326000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-3965000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-425000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3966000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5039000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
700000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
14490000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
90000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1079000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4949000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6911000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-25000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1297000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-816000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2279000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2487000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
982000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1671000
us-gaap Interest Paid Net
InterestPaidNet
285000
us-gaap Interest Paid Net
InterestPaidNet
590000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16000
us-gaap Income Taxes Paid
IncomeTaxesPaid
41000
emma Debt Discount Due To Conversion Of Features Derivative
DebtDiscountDueToConversionOfFeaturesDerivative
5555000
emma Debt Discount Due To Deferred Financing Cost
DebtDiscountDueToDeferredFinancingCost
134000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
394000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147000
CY2022Q2 us-gaap Depreciation
Depreciation
10000
CY2021Q2 us-gaap Depreciation
Depreciation
12000
CY2022Q2 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5441000
CY2020Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
2726000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
3414000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
42000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
2258000
us-gaap Net Income Loss
NetIncomeLoss
-10400000
CY2022Q2 emma Working Capital Deficit
WorkingCapitalDeficit
39500000
us-gaap Depreciation
Depreciation
21000
us-gaap Depreciation
Depreciation
23000
CY2020Q3 us-gaap Debt Instrument Call Date Earliest
DebtInstrumentCallDateEarliest
2020-09-28
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2021 us-gaap Other Income
OtherIncome
41000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52523286
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23326667
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4287000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6489000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11824000
CY2021Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5154000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
2799000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
-685000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
3197000
CY2021Q2 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
3840000
CY2020 us-gaap Other Income
OtherIncome
41000
CY2021Q4 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
91000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1288000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
579000
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1303000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1097000
CY2022Q2 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4520000
CY2022Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1441000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1439000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
362000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
115000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5739000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6228000
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4408000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3390000
CY2022Q2 us-gaap Inventory Net
InventoryNet
3134000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4392000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
378000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
660000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
435000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
326000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
422000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
394000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1235000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1380000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
496000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
541000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
411000
CY2022Q2 emma Cro Expenses
CROExpenses
537000
CY2021Q4 emma Cro Expenses
CROExpenses
534000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
615000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
477000
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1001000
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
932000
CY2022Q2 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
245000
CY2021Q4 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
378000
CY2022Q2 emma Accrued Non Employee Board Member Compensation
AccruedNonEmployeeBoardMemberCompensation
417000
CY2021Q4 emma Accrued Non Employee Board Member Compensation
AccruedNonEmployeeBoardMemberCompensation
136000
CY2022Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
192000
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
262000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3007000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2719000
CY2022Q2 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
227000
CY2021Q4 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4371000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
373000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
332000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6196000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5800000
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10718000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9189000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2791000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4404000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31694000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33173000
CY2022Q2 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
27023000
CY2022Q2 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
27023000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3696000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3696000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
23326000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
23326000
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
41062535
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
41062535
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2022Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.12
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.06
CY2022Q2 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.22
CY2021Q4 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.15
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
23763000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3260000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
27023000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y1M6D
emma Adjustment Of Warrants Change In Fair Value Increase Additional Paid In Capital And Accumulated Loss
AdjustmentOfWarrantsChangeInFairValueIncreaseAdditionalPaidInCapitalAndAccumulatedLoss
446000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
182000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
31000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
294000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
288000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
523000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1049000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1063000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1092000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
836000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4563000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
991000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3572000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3100000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.129
CY2022Q2 us-gaap Liabilities
Liabilities
80624000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49558501
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 emma Notes Payable Current Excluding Convertible Notes Payable Current
NotesPayableCurrentExcludingConvertibleNotesPayableCurrent
6394000
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
2871000
CY2021Q4 us-gaap Liabilities
Liabilities
78184000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
396000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
753000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49311864
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49311864
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-255000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241266000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56734000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6489000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
430000
CY2021Q2 us-gaap Gross Profit
GrossProfit
6059000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1453000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3370000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1290000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-615000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1336000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1175000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-191000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
225000
us-gaap Interest And Other Income
InterestAndOtherIncome
381000
us-gaap Interest Expense
InterestExpense
1707000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-4975000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6107000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-174000
us-gaap Net Income Loss
NetIncomeLoss
-5933000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46076000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2854000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31694000
CY2021Q4 emma Long Term Notes Payable Excluding Convertible Long Term Notes Payable
LongTermNotesPayableExcludingConvertibleLongTermNotesPayable
1500000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3150000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
643000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
974000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3772000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
538000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3084000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
761000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12664000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3027000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13518000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49311864
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49315952
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49193474
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34635000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45989000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4287000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-174000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Operating Lease Expense
OperatingLeaseExpense
597000
us-gaap Operating Lease Expense
OperatingLeaseExpense
589000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3600000
CY2021Q2 us-gaap Interest Expense
InterestExpense
653000
us-gaap Interest Expense
InterestExpense
2024000
CY2022Q2 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-7270000
CY2021Q2 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
1814000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-5847000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8710000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2297000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10355000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
182000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000

Files In Submission

Name View Source Status
0001564590-22-029481-index-headers.html Edgar Link pending
0001564590-22-029481-index.html Edgar Link pending
0001564590-22-029481.txt Edgar Link pending
0001564590-22-029481-xbrl.zip Edgar Link pending
emma-10q_20220630.htm Edgar Link pending
emma-20220630.xsd Edgar Link pending
emma-ex311_8.htm Edgar Link pending
emma-ex312_7.htm Edgar Link pending
emma-ex321_9.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
emma-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
emma-20220630_pre.xml Edgar Link unprocessable
emma-10q_20220630_htm.xml Edgar Link completed
emma-20220630_cal.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
emma-20220630_def.xml Edgar Link unprocessable